Methamphetamine and dopamine neurotoxicity: differential effects of agents interfering with glutamatergic transmission
Authors:
- Frangoise BordierFBFrangoise Bordier
- Pierre DubédatPDPierre Dubédat
- Adam DobleADAdam Doble
- 1 July 1995
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 195 (1) , 9-12
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The novel anticonvulsant lamotrigine prevents dopamine depletion in C57 black mice in the MPTP animal model of Parkinson's diseaseLife Sciences, 1994
- Riluzole and experimental parkinsonismNeuroReport, 1994
- Riluzole and experimental parkinsonismNeuroReport, 1994
- Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in miceBrain Research, 1994
- Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbensBrain Research, 1994
- Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stressThe Journal of Neuroscience, 1994
- NMDA antagonists partially protect against MPTP induced neurotoxicity in miceNeuroReport, 1993
- Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpineBritish Journal of Pharmacology, 1993
- Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivoNeuroscience Letters, 1992
- Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levelsEuropean Journal of Pharmacology, 1976